Cargando…
PAs as principal investigators of FDA-regulated clinical trials
A misconception exists that only physicians can be principal investigators for FDA-regulated human clinical trials such as interventional studies. This article reviews existing guidelines and dispels the notion that physician associates/assistants (PAs) cannot be principal investigators for clinical...
Autor principal: | Nalepinski, Colleen Elizabeth Gosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184706/ https://www.ncbi.nlm.nih.gov/pubmed/37026785 http://dx.doi.org/10.1097/01.JAA.0000931416.49268.b2 |
Ejemplares similares
-
Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials
por: Dombeck, Carrie B., et al.
Publicado: (2019) -
One and done: Reasons principal investigators conduct only one FDA-regulated drug trial
por: Corneli, Amy, et al.
Publicado: (2017) -
The acceptability of a novel procedure service run by PAs and NPs
por: Kim, Nancy, et al.
Publicado: (2021) -
An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
por: Chaloupka, Frank J, et al.
Publicado: (2015) -
Test des moteurs pas à pas
por: Daneels, A, et al.
Publicado: (1976)